Spectrum Pharmaceuticals reported $0 in Stock for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Amgen AMGN:US $ 4554M 143M
Astellas Pharma 4503:JP Y 164828M 11756M
Bayer BAYN:GR € 11371M 502M
Biogen BIIB:US $ 1294.2M 78.8M
Bristol Myers Squibb BMY:US $ 2142M 38M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Endo International Ordinary Shares ENDP:US $ 287.76M 3.93M
GlaxoSmithKline GSK:LN 4664M 1339M
Karyopharm Therapeutics KPTI:US $ 3.47M 404K
Novartis NOVN:VX SF 6880M 117M
Puma Biotechnology PBYI:US $ 6.66M 0.61M
Seattle Genetics SGEN:US $ 319.35M 43.61M
Takeda 4502:JP Y 927511M 74344M
Teva Pharmaceutical TEVA:IT 4.05B 37M
YTE INCY:US $ 54.5M 19.05M